✦ LIBER ✦

Phase II multicenter open-label study of karenitecin in previously treated epithelial ovarian and primary peritoneal cancer: a Gynecologic Oncology Group Study

✍ Scribed by J.J. KAVANAGH; M.W. SILL; P.T. RAMIREZ; D. WARSHAL; M.L. PEARL; M.A. MORGAN

No coin nor oath required. For personal study only.

📜 SIMILAR VOLUMES

Phase II Trial of Bevacizumab in Persist

✍ Burger, R. A.; Sill, M. W.; Monk, B. J.; Greer, B. E.; Sorosky, J. I. 📂 Article 📅 2007 🏛 American Society of Clinical Oncology 🌐 English ⚖ 112 KB

A phase I trial of gemcitabine and topot

✍ M. Dwight Chen; Gini F. Fleming; Suann Mitchell; Ira Horowitz 📂 Article 📅 2006 🏛 Elsevier Science 🌐 English ⚖ 95 KB

Phase I feasibility trial of carboplatin

✍ Katherine Y Look; Michael A Bookman; Jessie Schol; Thomas J Herzog; Thomas Rocer 📂 Article 📅 2004 🏛 Elsevier Science 🌐 English ⚖ 128 KB

A phase II study of vorinostat in the tr

✍ Susan C. Modesitt; Michael Sill; James S. Hoffman; David P. Bender 📂 Article 📅 2008 🏛 Elsevier Science 🌐 English ⚖ 251 KB

Cisplatin plus gemcitabine in platinum-r

✍ Cheryl A. Brewer; John A. Blessing; Robert A. Nagourney; Mark Morgan; Parviz Han 📂 Article 📅 2006 🏛 Elsevier Science 🌐 English ⚖ 121 KB

A phase II study of docetaxel in paclita

✍ Peter G Rose; John A Blessing; Harrison G Ball; James Hoffman; David Warshal; Ko 📂 Article 📅 2003 🏛 Elsevier Science 🌐 English ⚖ 78 KB